Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA

Yongdong Zhao(Seattle Children's Hospital), Timothy Beukelman(University of Alabama at Birmingham), Mary Beth F. Son(Boston Children's Hospital), Erin Sullivan(Seattle Children's Hospital)
Annals of the Rheumatic Diseases
January 27, 2022
10.1136/annrheumdis-2021-221694
Cited by 11

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
|Arthritis & Rheumatology|2020|537
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465